Literature DB >> 6411401

Immune complexes in Hodgkin's disease: isolation, immunochemical and physico-chemical analysis.

W Kilgallon, P L Amlot, B D Williams.   

Abstract

Immune complexes (IC) present in sera from patients with Hodgkin's disease (HD) were isolated using three different affinity columns: C1q-degalan, anti-C1q sepharose and conglutinin (K)-degalan. The isolated IC were analysed by immunoprecipitation, SDS-PAGE and sucrose density gradients and compared with IC similarly isolated from patients with rheumatoid arthritis (RA), systemic lupus erythematosus (SLE) and in vitro prepared BSA-anti-BSA complexes. Isolated material from each disease, and BSA-anti-BSA complexes contained proteins compatible with true immune complexes--IgM, IgG, C1q and C3 breakdown components. Albumin, fibronectin and CRP, whose affinity for IgM, C1q and C3 are known, were co-isolated along with IC material. The size of isolated IC in HD ranged from 8-40S on sucrose density gradients. Despite the operational difference in detecting and isolating HD complexes via the C1q ligand (C1q-degalan or anti-C1q column) and C3bi (K-degalan), material purified by both methods showed remarkable similarity on SDS-PAGE and immunoprecipitation analysis. Although IC isolated from different diseases showed disparate banding patterns on SDS-PAGE this was attributed to a variation in the relative concentrations of constituent proteins--IgM, IgG and C3 breakdown products. IgM, IgG and C3 bind loosely, and non-specifically, to macromolecular aggregates formed around immune complexes. Using the anti-C1q column, most of this material could be eluted using 0.02M EDTA. Least protein, yet the most specific for antigen and antibody was eluted at pH 3.0.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6411401      PMCID: PMC1535692     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  18 in total

1.  Solid-phase enzyme immunoassay or radioimmunoassay for the detection of immune complexes based on their recognition by conglutinin: conglutinin-binding test. A comparative study with 125I-labelled Clq binding and Raji-cell RIA tests.

Authors:  P Casali; A Bossus; N A Carpentier; P H Lambert
Journal:  Clin Exp Immunol       Date:  1977-08       Impact factor: 4.330

2.  Binding of albumin to gamma-A-myeloma proteins and Waldenström macroglobulins by disulfide bonds.

Authors:  M Mannik
Journal:  J Immunol       Date:  1967-11       Impact factor: 5.422

3.  Rabbit C1q: purification, functional and structural studies.

Authors:  J E Volanakis; R M Stroud
Journal:  J Immunol Methods       Date:  1972-11       Impact factor: 2.303

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Characterization of immune complexes in serum by adsorption on staphylococcal protein A: model studies and application to sera of rats bearing a gross virus-induced lymphoma.

Authors:  D F Tucker; R H Begent; N M Hogg
Journal:  J Immunol       Date:  1978-11       Impact factor: 5.422

6.  Correlation between immune complexes and prognostic factors in Hodgkin's disease.

Authors:  P L Amlot; B Pussell; J M Slaney; B D Williams
Journal:  Clin Exp Immunol       Date:  1978-02       Impact factor: 4.330

7.  Circulating immune complexes and symptoms in Hodgkin's disease.

Authors:  P L Amlot; J M Slaney; B D Williams
Journal:  Lancet       Date:  1976-02-28       Impact factor: 79.321

8.  Detection of immune complexes in unheated sera by modified 125I-Clq binding test. Effect of heating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus.

Authors:  R H Zubler; G Lange; P H Lambert; P A Miescher
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

9.  Purification of soluble immune complexes from serum using polymethylmetacrylate beads coated with conglutinin or C1q. Application to the analysis of the components of in vitro formed immune complexes and of immune complexes occurring in vivo during leishmaniasis.

Authors:  P Casali; P H Lambert
Journal:  Clin Exp Immunol       Date:  1979-08       Impact factor: 4.330

10.  Use of bovine conglutinin for the assay of immune complexes.

Authors:  R A Eisenberg; A N Theofilopoulos; F J Dixon
Journal:  J Immunol       Date:  1977-04       Impact factor: 5.422

View more
  3 in total

1.  An efficient one-step method for isolating immune complexes from whole serum using a monoclonal anti-C3g affinity immunosorbent.

Authors:  D J Samuel; P L Amlot; P Shepherd; P J Lachmann
Journal:  Clin Exp Immunol       Date:  1986-08       Impact factor: 4.330

2.  Demonstration of an unidentified 48 kD polypeptide in circulating immune complexes in rheumatoid arthritis.

Authors:  R D Melsom; P R Smith; R N Maini
Journal:  Ann Rheum Dis       Date:  1987-02       Impact factor: 19.103

3.  The stimulation of IgM rheumatoid factor from human B lymphocytes by rheumatoid arthritis complement-activating immune complexes.

Authors:  M Lorber; D Samuel; P Amlot; G S Panayi
Journal:  Clin Exp Immunol       Date:  1988-02       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.